Walleye Trading’s Revelation Biosciences, Inc. Unit REVBU Stock Holding History

Walleye Trading’s Portfolio REVBU Stock Details REVBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-104,022	Closed	-$20.8K	–	5720
2022 Q4	$20.8K	Hold	104,022	–	–	﹤0.01%	4369
2022 Q3	$33K	Buy	+104,022	New	+$71.8K	﹤0.01%	4335
2021 Q1	–	Sell	-48,440	Closed	-$523K	–	5496
2020 Q4	$523K	Buy	+48,440	New	+$492K	﹤0.01%	2614

Walleye Trading's REVBU Position: Q1 2023 in Review

Walleye Trading sold out of Revelation Biosciences, Inc. Unit (REVBU) in Q1 2023, closing a stake of 104,022 shares — an estimated $20.8K sold.

Walleye Trading first reported a position in REVBU in Q4 2020 and held it in 3 quarters. The position peaked at $523K in Q4 2020. 0 funds tracked by Wall St. Rank hold REVBU as of Q1 2023.

Walleye Trading reported no remaining Revelation Biosciences, Inc. Unit position as of Q1 2023 after selling out during the quarter.
Walleye Trading sold 104,022 Revelation Biosciences, Inc. Unit shares in Q1 2023, an estimated $20.8K.
Walleye Trading first reported a position in Revelation Biosciences, Inc. Unit in Q4 2020 and held it in 3 quarters.
Walleye Trading's Revelation Biosciences, Inc. Unit position peaked at $523K in Q4 2020.
0 funds tracked by Wall St. Rank held Revelation Biosciences, Inc. Unit as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.